Implementation of Antimicrobial Stewardship (AMS): An Imperative Step to Reducing Resistance and Improving Infectious Disease Cure Rates
Asian Journal of Medical Principles and Clinical Practice, Volume 5, Issue 4,
Page 198-204
Abstract
The discovery of penicillin in 1940 by Alexandra Fleming brought a major breakthrough in the management of infectious diseases and further sparked special interest in the research and development of antimicrobial agents. However, in a matter of time, penicillin like the sulphonamide that predates it had to battle the evolution of antibiotics resistance as microbes threw out their strong offensives against this wonder drug. Over the years, we have seen the introduction of several other groups of antibiotics, from streptomycin to chloramphenicol, macrolides, aminoglycosides, ampicillin, and cephalosporins. But we still have had to combat the same problem of resistance against each of these newer agents. In the light of this, we moved towards drug combinations in order to mitigate the effect of resistance especially for the “Hospital Acquired Infections’”. These combinations lead to better cure rate or more synergistic results. The sad news however is that treatment cost for infectious diseases continues to skyrocket while microbes acquire more virulent and resistant powers. The “cidal and static" actions of antibiotics left microbes with two options. To die or fight back. They choose the latter, hence, our predicament. Antimicrobial stewardship (AMS) seems to be the single most important way left in curbing resistance crises. The implementation of AMS in our various healthcare facilities in line with WHO protocols is an imperative step to improving infectious disease cure rates and stopping the emergence of new forms of bacterial resistance. However, the big question is “to what extent has this important policy been implemented in the healthcare institutions especially in developing countries of the world. There is a serious need for both the private and public healthcare facilities to prioritize AMS and join hands in the global fight against antimicrobial resistance.
- Antimicrobial
- stewardship
- resistance
- disease
- infections
- healthcare
- health professionals
How to Cite
References
Mohamed A. Baraka et al. Health Care Providers’ Perceptions regarding Antimicrobial Stewardship Programs (AMS) Implementation-Facilitators and Challenges: a Cross-Sectional Study in the Eastern Province of Saudi Arabia. Annals of Clinical Microbiology and Antimicrobials. 2019;18(1):26.
Shira Doron, and Lisa E. Davidson, “Antimicrobial Stewardship.” Mayo Clinic Proceedings, 2011;86(11):1113–23.
Rebecca Lester et al., Sustained Reduction in Third-Generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi. Clinical Infectious Diseases. 2020;71(9):e478–86.
Evelina Tacconelli et al. STROBE-AMS: Recommendations to Optimise Reporting of Epidemiological Studies on Antimicrobial Resistance and Informing Improvement in Antimicrobial Stewardship. BMJ Open. 2016;6(2):e010134.
African Union Centers for Disease Control and Prevention. Africa CDC Framework for Antimicrobial Resistance (2018):3–24: 2018–23.
Dyar et al OJ. What Is Antimicrobial Stewardship?. Clinical Microbiology and Infection. 2017;23(11):793–8.
US Department of Health and Human Services. Causes of Antimicrobial (Drug) Resistance. National Institute of Allergy and Infectious Diseases; 2022.
Available:https://www.niaid.nih.gov/research/antimicrobial-resistance-causes.
Diarmaid Hughes, and Dan I. Andersson, Environmental and Genetic Modulation of the Phenotypic Expression of Antibiotic Resistance. FEMS Microbiology Reviews. 2017;41(3):374–91.
Lauren Floris, PD PPRBRMCB. Understanding antimicrobial resistance. U.S, Pharmacist – the Leading. Journal in Pharmacy; 2022.
Available:https://www.uspharmacist.com/article/understanding-antimicrobial-resistance.
Papreen Nahar et al. What Contributes to Inappropriate Antibiotic Dispensing Among Qualified and Unqualified Healthcare Providers in Bangladesh? A Qualitative Study. BMC Health Services Research. 2020;20(1):656.
DOI: 10.1186/s12913-020-05512-y
Calva J, Bojalil R. Antibiotic Use in a Peri-urban Community in Mexico: a Household and Drugstore Survey. Social Science and Medicine. 1996;42(8): 121–8.
Ali Karimi, Maedeh Majlesi, Mahmoud Rafieian-Kopaei. Herbal Versus Synthetic Drugs; Beliefs and Facts. Journal of Nephropharmacology. 2015;4(1):27–30.
Michael R. Gillings, Stokes HW. Are Humans Increasing Bacterial Evolvability?. Trends in Ecology and Evolution. 2012;27(6):346–52.
Emily Leung et al., W.H.O. Policy Package to Combat Antimicrobial Resistance.” Bulletin of the World Health Organization 2011p89(5):390–2.
Wanda C. Reygaert, An Overview of the Antimicrobial Resistance Mechanisms of Bacteria. AIMS Microbiology. 20184(3): 482–501.
Manar Ali Abushaheen et al., Muzaheed and A.J. Fatani et al. Antimicrobial Resistance, Mechanisms and Its Clinical Significance. Disease-A-Month. 2020;66(6): 100971.
Denis K. Byarugaba. Mechanisms of Antimicrobial Resistance. in Antimicrobial Resistance in Developing Countries. Springer ScienceþBusiness Media. LLC. 2010;15–26.
Alison H. Holmes, Luke SP. Moore, Arnfi Nn Sundsfj Ord, Martin Steinbakk, Sadie Regmi, Abhilasha Karkey, Philippe J Guerin, Laura J V Piddock. Understanding the Mechanisms and Drivers of Antimicrobial Resistance; 2015.
Available: http://www.thelancet.com. DOI: 10.1016/S0140-6736(15)00473-0.
Chew-Li Moo et al., Swee-Hua-Erin Lim, and Kok-Song Lai. Current Drug Discovery Technologies. Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR. 2019; 17(0).
Levy SB. Active Efflux, a Common Mechanism for Biocide and Antibiotic Resistance. Journal of Applied Microbiology Symposium Supplement. 2002;92:65S–71S.
Steven L. Solomon, Kristen B. Oliver. Antibiotic Resistance Threats in the United States: Stepping Back from the Brink. American Family Physician. 2014;89(12):938–41.
Daniel J. Shapiro et al. Antibiotic Prescribing for Adults in Ambulatory Care in the USA, 2007–09.” Journal of Antimicrobial Chemotherapy. 2014;69(1):234–40.
DOI: 10.1093/jac/dkt301. Epub July 25 2013. PubMed: 23887867
Conan MacDougall, and Ron E. Polk, Antimicrobial Stewardship Programs in Health Care Systems. Clinical Microbiology Reviews. 2005;18(4):638–56.
Rajesh R. Uchil et al. Strategies to Combat Antimicrobial Resistance. Journal of Clinical and Diagnostic Research. 2014; 8(7):ME01–4.
ASHP Statement on the Pharmacist’s Role in Antimicrobial Stewardship and Infection Prevention and Control. American Journal of Health-System Pharmacy. 2010;67(7): 575–7.
Richard N. Olans, Rita D. Olans, Alfred DeMaria Jr., The Critical Role of the Staff Nurse in Antimicrobial Stewardship—Unrecognized, but Already There. Clinical Infectious Diseases. 2016;62(1):84–9.
-
Abstract View: 329 times
PDF Download: 47 times
